LTA4H, leukotriene A4 hydrolase, 4048

N. diseases: 63; N. variants: 11
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma
0.200 Biomarker group RGD Leukotriene A4 hydrolase in rat and human esophageal adenocarcinomas and inhibitory effects of bestatin. 12865451 2003
CUI: C1292753
Disease: Primary Effusion Lymphoma
Primary Effusion Lymphoma
0.010 AlteredExpression disease BEFREE Leukotriene A4 hydrolase expression in PEL cells is regulated at the transcriptional level and leads to increased leukotriene B4 production. 16709867 2006
CUI: C4520841
Disease: Pure Erythroid Leukemia
Pure Erythroid Leukemia
0.010 AlteredExpression disease BEFREE Leukotriene A4 hydrolase expression in PEL cells is regulated at the transcriptional level and leads to increased leukotriene B4 production. 16709867 2006
CUI: C0376358
Disease: Malignant neoplasm of prostate
Malignant neoplasm of prostate
0.010 GeneticVariation disease BEFREE LTA4H rs1978331 was inversely associated with prostate cancer risk overall (unadjusted, overdominant model OR = 0.68, 95% CI: 0.51-0.91 for TC vs. TT/CC). 21308720 2011
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.010 GeneticVariation disease BEFREE LTA4H rs1978331 was inversely associated with prostate cancer risk overall (unadjusted, overdominant model OR = 0.68, 95% CI: 0.51-0.91 for TC vs. TT/CC). 21308720 2011
CUI: C0041327
Disease: Tuberculosis, Pulmonary
Tuberculosis, Pulmonary
0.030 Biomarker disease BEFREE LTA4H, IL10 and IFNG SNPs showed no associations with pulmonary tuberculosis. 25239251 2015
CUI: C0041318
Disease: Tuberculosis, Meningeal
Tuberculosis, Meningeal
0.060 GeneticVariation disease BEFREE LTA4H gene were significantly associated with tuberculous meningitis, lymph node tuberculosis, bone tuberculosis and other extra-pulmonary tuberculosis except for pleural tuberculosis. 25257262 2014
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.010 Biomarker phenotype BEFREE Leukotriene A4 hydrolase (LTA<sub>4</sub>H) is a proinflammatory enzyme that generates the inflammatory mediator leukotriene which may play an important role in chronic inflammation associated carcinogenesis. 28065501 2017
Human immunodeficiency virus (HIV) II infection category B1
0.010 GeneticVariation disease BEFREE LTA4H genotype predicted survival of human immunodeficiency virus (HIV)-uninfected patients, with TT-genotype patients significantly more likely to survive TBM than CC-genotype patients, according to Cox regression analysis (univariate P = .040 and multivariable P = .037). 28419368 2017
CUI: C0019693
Disease: HIV Infections
HIV Infections
0.010 GeneticVariation group BEFREE LTA4H genotype and HIV infection influence pretreatment inflammatory phenotype and survival from TBM. 28419368 2017
CUI: C0041318
Disease: Tuberculosis, Meningeal
Tuberculosis, Meningeal
0.060 GeneticVariation disease BEFREE LTA4H genotype and HIV infection influence pretreatment inflammatory phenotype and survival from TBM. 28419368 2017
CUI: C0007114
Disease: Malignant neoplasm of skin
Malignant neoplasm of skin
0.010 Biomarker disease BEFREE LTA4H depletion dramatically decreased anchorage-dependent and -independent skin cancer cell growth by inducing cell cycle arrest at the G0/G1 phase. 28575166 2017
CUI: C0004096
Disease: Asthma
Asthma
0.280 Biomarker disease BEFREE Leukotriene A4 Hydrolase Activation and Leukotriene B4 Production by Eosinophils in Severe Asthma. 30352167 2019
CUI: C0009402
Disease: Colorectal Carcinoma
Colorectal Carcinoma
0.010 AlteredExpression disease BEFREE LTA4H and BLT1 are overexpressed in CRC and associated with CRC survival probability. 31085102 2019
CUI: C0523465
Disease: Serum albumin measurement
Serum albumin measurement
0.100 GeneticVariation phenotype GWASDB A genome-wide assessment of variability in human serum metabolism. 23281178 2013
CUI: C0041318
Disease: Tuberculosis, Meningeal
Tuberculosis, Meningeal
0.060 GeneticVariation disease BEFREE Adjunctive dexamethasone saves lives in the treatment of tuberculous meningitis but this response is influenced by the patient's LTA4H genotype. 25799317 2015
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
0.010 AlteredExpression disease BEFREE All pre-B-ALL clones expressed genes coding for 5-lipoxygenase activating protein (FLAP), leukotriene A4 hydrolase and prostaglandin (PG)H synthase 1. 7646998 1995
Precursor B-cell lymphoblastic leukemia
0.010 AlteredExpression disease BEFREE All pre-B-ALL clones expressed genes coding for 5-lipoxygenase activating protein (FLAP), leukotriene A4 hydrolase and prostaglandin (PG)H synthase 1. 7646998 1995
CUI: C0004096
Disease: Asthma
Asthma
0.280 Biomarker disease BEFREE ALOX5AP and LTA4H are associated with asthma susceptibility, suggesting a role for LTB4 in disease. 23167751 2012
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.060 Biomarker disease BEFREE Although there was limited inter-study concordance of important loci, two gene variants in the leukotriene pathway (ALOX5AP and LTA4) have emerged as susceptibility factors for myocardial infarction (MI). 16987874 2006
CUI: C0021390
Disease: Inflammatory Bowel Diseases
Inflammatory Bowel Diseases
0.010 Biomarker group BEFREE Catalase (p < 0.0001) and LTA4H (p = 0.0002) were elevated in IBD stool samples compared to non-IBD stool samples. 29531307 2018
CUI: C0280324
Disease: Laryngeal Squamous Cell Carcinoma
Laryngeal Squamous Cell Carcinoma
0.010 Biomarker disease BEFREE Collectively, the identification of FSCN1-binding partners enhances understanding of the mechanism of FSCN1-mediated malignant phenotypes, and these findings indicate that FSCN1 binds to AIMP1 and LTA4H might promote the progression of LSCC. 31287215 2019
CUI: C0524620
Disease: Metabolic Syndrome X
Metabolic Syndrome X
0.010 AlteredExpression disease BEFREE Comparison of gene expression pattern between CAD and MetS revealed significantly higher expression of leukotriene genes - arachidonate 5-lipoxygenase (ALOX5), arachidonate 5-lipoxygenase activating protein (ALOX5 AP), leukotriene A4 hydrolase (LTA4H) and leukotriene C4 synthase (LTC4S), and lower expression of NF-κB, interleukin 1 beta (IL-1β), monocyte chemoattractant protein-1 (MCP-1/CCL2) and signal transducer and activator of transcription 3 (STAT3) genes in CAD. 29067980 2017
CUI: C1956346
Disease: Coronary Artery Disease
Coronary Artery Disease
0.020 AlteredExpression disease BEFREE Comparison of gene expression pattern between CAD and MetS revealed significantly higher expression of leukotriene genes - arachidonate 5-lipoxygenase (ALOX5), arachidonate 5-lipoxygenase activating protein (ALOX5 AP), leukotriene A4 hydrolase (LTA4H) and leukotriene C4 synthase (LTC4S), and lower expression of NF-κB, interleukin 1 beta (IL-1β), monocyte chemoattractant protein-1 (MCP-1/CCL2) and signal transducer and activator of transcription 3 (STAT3) genes in CAD. 29067980 2017
CUI: C3665444
Disease: Neutrophilia (disorder)
Neutrophilia (disorder)
0.010 Biomarker disease BEFREE Components of cigarette smoke can acetylate PGP, yielding a species (AcPGP) that is resistant to LTA4H-mediated degradation and can, thus, support a sustained neutrophilia. 29202450 2017